Skip to main content

Table 1 Clinical baseline characteristics of patients with type 2 diabetes

From: Analysis of risk factors for carotid intima-media thickness in patients with type 2 diabetes mellitus in Western China assessed by logistic regression combined with a decision tree model

Variable Total
N = 1372
CIMT(−) group
N = 965
CIMT(+) group
N = 407
 P
Gender (male/female) 843/529 (61.4%, 38.6%) 558/407 (57.8%, 42.2%) 285/122 (70%, 30%) 0.000a**
Smoking (no/yes) 809/563 (59.0%, 41.0%) 654/311 (67.8%, 32.2%) 155/252 (38.1%, 61.9%) 0.000a**
Age (years) 53.66 ± 11.44 53.04 ± 11.49 55.12 ± 11.20 0.001b**
Heart rate (beat/min) 75.51 ± 10.86 75.85 ± 10.94 74.70 ± 10.64 0.042b*
SBP (mm/Hg) 126.42 ± 16.28 125.37 ± 16.07 128.90 ± 16.51 0.000b**
DBP (mm/Hg) 76.52 ± 9.86 76.05 ± 9.70 77.64 ± 10.16 0.005b**
Height (cm) 161.77 ± 9.25 161.42 ± 9.15 162.60 ± 9.44 0.013b*
Weight (kg) 67.09 ± 12.64 66.15 ± 12.40 69.32 ± 12.94 0.000b**
BMI (kg/m2) 25.42 ± 3.60 25.19 ± 3.57 25.98 ± 3.61 0.000b**
Waist circumference (cm) 88.74 ± 9.29 87.99 ± 9.22 90.50 ± 9.22 0.000b**
Hip circumference (cm) 96.30 ± 7.21 95.95 ± 7.27 97.12 ± 7.01 0.004b**
WHR 0.921 ± 0.07 0.92 ± 0.08 0.93 ± 0.07 0.006b**
VFA (cm2) 86.34 ± 39.82 82.54 ± 38.23 95.34 ± 42.05 0.000b**
SFA (cm2) 172.54 ± 60.80 168.42 ± 60.26 182.33 ± 61.01 0.000b**
Glu0 (mmol/L) 9.55 ± 3.57 9.58 ± 3.76 9.46 ± 3.08 0.678b
Glu120 (mmol/L) 14.84 ± 4.98 14.69 ± 4.94 15.20 ± 5.05 0.056b
Ins0 (µIU/mL) 9.31 ± 5.90 9.21 ± 5.94 9.56 ± 5.80 0.316b
Ins120 (µIU/mL) 24.03 ± 18.78 23.76 ± 18.93 24.67 ± 18.42 0.258b
C0 (µg/L) 1.48 ± 1.18 1.45 ± 1.19 1.55 ± 1.17 0.126b
C120 (µg/L) 3.41 ± 9.23 3.40 ± 10.61 3.43 ± 4.46 0.023b*
HbA1C (%) 9.28 ± 2.39 9.23 ± 2.42 9.39 ± 2.33 0.280b
eGFR (mL/min/1.73m2) 137.05 ± 112.14 135.57 ± 67.83 140.57 ± 177.56 0.015b*
BUN (mmol/L) 5.346 ± 10.84 5.41 ± 12.80 5.21 ± 2.73 0.002b**
Scr (µmol/L) 64.18 ± 20.69 63.18 ± 20.06 66.54 ± 21.95 0.002b**
UA (µmol/L) 332.75 ± 95.49 329.98 ± 95.37 339.31 ± 95.57 0.022b**
TG (mmol/L) 2.72 ± 2.51 2.81 ± 2.66 2.53 ± 2.10 0.436b
TC (mmol/L) 4.61 ± 1.33 4.64 ± 1.35 4.54 ± 1.28 0.166b
HDL-c (mmol/L) 1.34 ± 4.29 1.40 ± 5.11 1.19 ± 0.40 0.006b**
LDL-c (mmol/L) 2.30 ± 0.90 2.29 ± 0.90 2.34 ± 0.88 0.497b
L-CIMT (mm) 1.49 ±1.83 0.73 ± 0.13 3.29 ± 2.57 0.000b**
R-CIMT (mm) 1.48 ± 1.83 0.72 ± 0.13 3.26 ± 2.71 0.000b**
Mean value of CIMT (mm) 1.48 ± 1.84 0.73 ± 0.13 3.27 ± 2.62 0.000b**
L-ABI 1.14 ± 0.09 1.14 ± 0.08 1.15 ± 0.09 0.057b
R-ABI 1.14 ± 0.09 1.14 ± 0.08 1.15 ± 0.09 0.051b
Mean value of ABI 1.14 ± 0.08 1.14 ± 0.08 1.15 ± 0.08 0.055b
  1. SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WHR waist hip ratio, VFA visceral fat area, SFA subcutaneous fat area, Glu0 fasting blood glucose, Glu120 2-hour postprandial blood glucose, Ins0 fasting serum insulin, Ins120 2-hour postprandial serum insulin, C0 fasting serum C peptide, C120 2-hour postprandial serum C-peptide, HbA1C glycated hemoglobin A1c, eGFR estimated glomerular filtration rate, BUN blood urea nitrogen, Scr serum creatinine, UA uric acid, TG triglyceride, TC cholesterol, HDL-c high density lipoprotein cholesterol, LDL-c low density lipoprotein cholesterol, CIMT carotid intima media thickness, L-CIMT left carotid intima media thickness, R-CIMT right carotid intima media thickness, ABI ankle brachial index, L-ABI left ankle brachial index, R-ABI right ankle brachial index
  2. aChi-square test
  3. bMann-Whitney’s U test
  4. *P<0.05, **P<0.01